We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalised lists.

NZSE - Delayed Quote NZD

Rua Bioscience Limited Rights ( (RUARA.NZ)

0.0070

-0.0010

(-12.50%)

As of 19 November at 9:59 am NZDT. Market open.

Key events

Loading Chart for RUARA.NZ

9/21 12:03 PM

DELL

Previous close 0.0080
Open 0.0070
Bid 0.0060 x --
Ask 0.0070 x --
Day's range 0.0070 - 0.0070
52-week range 0.0070 - 0.0070
Volume 21,989
Avg. Volume --
Market cap (intra-day) --
Beta (5Y monthly) --
PE ratio (TTM) --
EPS (TTM) --
Earnings date --
Forward dividend & yield --
Ex-dividend date --
1y target est --

EBOS Group (NZSE:EBO) Has Some Way To Go To Become A Multi-Bagger

EBOS Group (NZSE:EBO) Has Some Way To Go To Become A Multi-Bagger

Infratil First Half 2025 Earnings: NZ$0.26 loss per share (vs NZ$1.38 profit in 1H 2024)

Infratil First Half 2025 Earnings: NZ$0.26 loss per share (vs NZ$1.38 profit in 1H 2024)

Infratil Ltd (ASX:IFT) Half Year 2025 Earnings Call Highlights: Strong Performance Amid Market ...

Investing in Chorus (NZSE:CNU) five years ago would have delivered you a 113% gain

Investing in Chorus (NZSE:CNU) five years ago would have delivered you a 113% gain

Institutions along with individual investors who hold considerable shares inEBOS Group Limited (NZSE:EBO) come under pressure; lose 4.0% of holdings value

Institutions along with individual investors who hold considerable shares inEBOS Group Limited (NZSE:EBO) come under pressure; lose 4.0% of holdings value

Institutions own 34% of Mainfreight Limited (NZSE:MFT) shares but individual investors control 48% of the company

Institutions own 34% of Mainfreight Limited (NZSE:MFT) shares but individual investors control 48% of the company

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Do Infratil's (NZSE:IFT) Earnings Warrant Your Attention?

Do Infratil's (NZSE:IFT) Earnings Warrant Your Attention?

Mainfreight Limited (NZSE:MFT) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Mainfreight Limited (NZSE:MFT) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Fisher & Paykel Healthcare (NZSE:FPH) Faces Profit Challenges Despite Strong Revenue and Product Innovation

Fisher & Paykel Healthcare (NZSE:FPH) Faces Profit Challenges Despite Strong Revenue and Product Innovation

Chorus Ltd (CHRYY) (FY 2024) Earnings Call Highlights: Strong Fibre Growth Amidst Net Loss ...

Chorus Ltd (CHRYY) (FY 2024) Earnings Call Highlights: Strong Fibre Growth Amidst Net Loss ...

Select to analyse similar companies using key performance metrics; select up to four stocks.

Rua Bioscience Limited Rights (

0.0070

-12.50%

Mkt cap NZD -

Industry -

Valuation measures

As of

Market cap

--
Enterprise value

--
Trailing P/E

--
Forward P/E

--
PEG ratio (5-yr expected)

--
Price/sales (ttm)

--
Price/book (mrq)

--
Enterprise value/revenue

--
Enterprise value/EBITDA

--

Financial highlights

Profitability and income statement

Profit margin

--
Return on assets (ttm)

--
Return on equity (ttm)

--
Revenue (ttm)

--
Net income avi to common (ttm)

--
Diluted EPS (ttm)

--

Balance sheet and cash flow

Total cash (mrq)

--
Total debt/equity (mrq)

--
Levered free cash flow (ttm)

--